TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35305587

Group type: EXPERIMENTAL
Intervention: Family-based cognitive behavioural therapy (FCBT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Family-based psychoeducation and relaxation training (FPRT)
Number of subjects: 128
Study: 33427179

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch‐Up (ABC) intervention
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 85
Study: 33477443

Group type: EXPERIMENTAL
Intervention: Mohana Choorna (Ayurvedic herbal preparation)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 33322022

Group type: EXPERIMENTAL
Intervention: 800 mg of epigallocatechin gallate (EGCG) and 60 mL of coconut oil daily for 4 months
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51
Study: 34074541

Group type: EXPERIMENTAL
Intervention: Bikini incision
Number of subjects: 195

Group type: COMPARATOR
Intervention: Longitudinal incision
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 195
Study: 32150661

Group type: EXPERIMENTAL
Intervention: Everolimus at a dose of 6 mg/m2
Number of subjects: 0
Study: 34157162

Group type: EXPERIMENTAL
Intervention: FCL combined with intradermal injection of plasma gel
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: FCL combined with topical application of plasma gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: FCL monotherapy
Number of subjects: 30
Study: 34273811

Group type: EXPERIMENTAL
Intervention: Darolutamide 600 mg twice daily
Number of subjects: 1509

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1509
Study: 35115208

Group type: EXPERIMENTAL
Intervention: Individualized dietary advice
Number of subjects: 136
Study: 32057371

Group type: EXPERIMENTAL
Intervention: Ticagrelor plus placebo
Number of subjects: 51

Group type: COMPARATOR
Intervention: Ticagrelor plus ASA
Number of subjects: 51
Study: 36081217

Group type: EXPERIMENTAL
Intervention: Fluoxetine for 26 weeks
Number of subjects: 1221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1221

Group type: EXPERIMENTAL
Intervention: Fluoxetine and Placebo
Number of subjects: 1221
Study: 32974688

Group type: EXPERIMENTAL
Intervention: Deep learning algorithm for detection of PSC-compatible cholangiographic changes on 3D-MRCP images.
Number of subjects: 428
Study: 35772622

Group type: EXPERIMENTAL
Intervention: Antimicrobial Photodynamic Therapy with methylene blue (300 µmol/L)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Antimicrobial Photodynamic Therapy with curcumin (8 µmol/L)
Number of subjects: 108
Study: 34607196

Group type: EXPERIMENTAL
Intervention: Neuroaspis PLP10™ (20 ml once daily for 30 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (pure virgin olive oil, 20 ml once daily for 30 months)
Number of subjects: 40
Study: 35172891

Group type: EXPERIMENTAL
Intervention: Intravenous imatinib mesylate 200 mg bis in die (b.i.d.) for 7 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo IV infusion for 7 days
Number of subjects: 90
Study: 32696258

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg/kg/h IV infusion for 24 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine (10 μg/kg/h IV infusion for 24 h)
Number of subjects: 0
Study: 32818647

Group type: EXPERIMENTAL
Intervention: PDT with toluidine blue
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: PDT with methylene blue
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control
Number of subjects: 72
Study: 35183168

Group type: EXPERIMENTAL
Intervention: Subsidized eyeglasses provided to myopic children in treatment schools
Number of subjects: 13100

Group type: COMPARATOR
Intervention: Prescription information provided without subsidized eyeglasses in control schools
Number of subjects: 13100
Study: 33191851

Group type: EXPERIMENTAL
Intervention: Computer-assisted volumetry (CAV)
Number of subjects: 517

Group type: COMPARATOR
Intervention: ABC/2
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Both ABC/2 and CAV
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: CAV
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: ABC/2 and CAV
Number of subjects: 517
Study: 32727831

Group type: EXPERIMENTAL
Intervention: Xpert alone
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: LAM alone
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Sequential Xpert followed by LAM
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Concurrent testing with LAM + Xpert
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Any positive TB-specific test
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Cost per TB case diagnosed for sequential and concurrent strategies
Number of subjects: 561
Study: 33971606

Group type: EXPERIMENTAL
Intervention: DNA metabarcoding
Number of subjects: 22

Group type: COMPARATOR
Intervention: Morphological method
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 22
Study: 34905482

Group type: EXPERIMENTAL
Intervention: Low-intensity magnetic stimulation (LIMS) plus standard pharmacological treatment
Number of subjects: 560

Group type: COMPARATOR
Intervention: Standard pharmacological treatment
Number of subjects: 560
Study: 33218519

Group type: EXPERIMENTAL
Intervention: Fascial Manipulation (FM) for the right brachial fascia for 210 seconds
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fascial Manipulation (FM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Static Stretching (SS) of the right biceps brachii for 210 seconds
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (C) supine for 210 seconds
Number of subjects: 60
Study: 34039520

Group type: EXPERIMENTAL
Intervention: New classification system for fatty infiltration of the gluteus minimus using plain computed tomography (CT)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Goutallier classification system
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: New classification system for fatty infiltration of the gluteus minimus
Number of subjects: 71
Study: 34534858

Group type: EXPERIMENTAL
Intervention: CBT-T (Cognitive Behaviour Therapy emphasizing early behaviour change and body image improvement)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: CBTm (Cognitive Behaviour Therapy including motivational work and no body image content)
Number of subjects: 98
Study: 34130959

Group type: EXPERIMENTAL
Intervention: Induction of labour (IoL)
Number of subjects: 871

Group type: COMPARATOR
Intervention: Expectant management (EM)
Number of subjects: 871

Group type: EXPERIMENTAL
Intervention: Neurodevelopmental assessment at 10-12 years of age
Number of subjects: 871

Group type: EXPERIMENTAL
Intervention: Parent questionnaires
Number of subjects: 871

Group type: EXPERIMENTAL
Intervention: Teacher Report Form
Number of subjects: 871
Study: 32678777

Group type: EXPERIMENTAL
Intervention: Intervention group (public speaking anxiety)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no stress exposure)
Number of subjects: 32
Study: 32495666

Group type: EXPERIMENTAL
Intervention: Permethrin 5% cream applied on two occasions within a one-week interval (Group A)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Intensive application of permethrin 5% cream (Group B)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Retreatment according to the intense scheme (Group C)
Number of subjects: 55
Study: 32777156

Group type: EXPERIMENTAL
Intervention: DCARER system (digital group)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Traditional method (traditional group)
Number of subjects: 143
Study: 36364742

Group type: EXPERIMENTAL
Intervention: NO3−/NO2− supplementation (beetroot juice containing 250 mg nitrate and 20 mg nitrite/day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: NO3−/NO2− supplementation
Number of subjects: 36
Study: 34382886

Group type: EXPERIMENTAL
Intervention: Nurse-family partnership model
Number of subjects: 0
Study: 34403329

Group type: EXPERIMENTAL
Intervention: Self-selected exercise group (SSE)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Pre-determined exercise group (PDE)
Number of subjects: 46
Study: 32562684

Group type: EXPERIMENTAL
Intervention: 15 μg PD01A
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 75 μg PD01A
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Booster immunisation (75 μg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All patients (combined)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Systemic treatment-related adverse events
Number of subjects: 24
Study: 35026180

Group type: EXPERIMENTAL
Intervention: NTHi-Mcat vaccine
Number of subjects: 606

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 606
Study: 33621322

Group type: EXPERIMENTAL
Intervention: Incentive programs with varying amounts (hypothetical)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Incentive programs (hypothetical)
Number of subjects: 203
Study: 32568400

Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy (NOT) administered at 3 L/min by nasal cannula during nights at 2048 m
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (room air) administered during nights at 2048 m
Number of subjects: 32
Study: 35346534

Group type: EXPERIMENTAL
Intervention: Seeking Safety (cognitive-behavioral intervention for PTSD+SUD)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Women's Health Education (control)
Number of subjects: 88
Study: 32826644

Group type: EXPERIMENTAL
Intervention: KPI-121 0.25%
Number of subjects: 1430

Group type: COMPARATOR
Intervention: Vehicle drops
Number of subjects: 1430
Study: 35415884

Group type: EXPERIMENTAL
Intervention: Self-reported vaccination status for the season preceding the survey
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Self-reported vaccination status for the fifth preceding season
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Agreement between self-report and documented vaccination status for the fifth season
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Agreement between self-report and documented vaccination status for the season preceding interview
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Errors in recall for HCP vaccinated for only some of the preceding five seasons
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Errors in recall for HCP vaccinated all five preceding seasons
Number of subjects: 683
Study: 34339102

Group type: EXPERIMENTAL
Intervention: Thigh-length elastic pressure socks (intervention group, n=35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine nursing care (control group, n=35)
Number of subjects: 70
Study: 32653015

Group type: COMPARATOR
Intervention: Standard of care only
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Standard of care and lopinavir/ritonavir
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Standard of care and hydroxychloroquine
Number of subjects: 80
Study: 35902817

Group type: EXPERIMENTAL
Intervention: SARS‐CoV‐2 vaccines (first two licensed in Switzerland)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Trial platform implementation
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Trial platform efficiency
Number of subjects: 380
Study: 33076714

Group type: EXPERIMENTAL
Intervention: Interferon (IFN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxyurea
Number of subjects: 0
Study: 34974277

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) plus Oral-Motor Training (OMT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham Taping plus Oral-Motor Training (OMT)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (KT + OMT and Sham Taping + OMT)
Number of subjects: 18
Study: 34452940

Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas (LPG) cookstoves
Number of subjects: 1414

Group type: EXPERIMENTAL
Intervention: Improved biomass cookstoves
Number of subjects: 1414

Group type: COMPARATOR
Intervention: Control group (traditional stoves)
Number of subjects: 1414
Study: 33151187

Group type: EXPERIMENTAL
Intervention: Dynamic navigation using trace registration (TR) technology
Number of subjects: 39

Group type: COMPARATOR
Intervention: Free-hand surgery
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both TR and free-hand implants
Number of subjects: 39
Study: 33640979

Group type: EXPERIMENTAL
Intervention: Tele-Savvy (active arm)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 261

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 261
Study: 33964394

Group type: EXPERIMENTAL
Intervention: Live observational scoring
Number of subjects: 18

Group type: COMPARATOR
Intervention: Delayed video review
Number of subjects: 18
Study: 34341306

Group type: EXPERIMENTAL
Intervention: Fibrin Sealant
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hypospadias Repair (Control)
Number of subjects: 40
Study: 35412965

Group type: EXPERIMENTAL
Intervention: Traditional hypnotherapy
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Ericksonian hypnotherapy
Number of subjects: 144

Group type: COMPARATOR
Intervention: Educational talk
Number of subjects: 144
Study: 33513226

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (2000 IU/day)
Number of subjects: 771

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 771
Study: 36513465

Group type: EXPERIMENTAL
Intervention: Synbiotic plus vitamin D
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Synbiotic
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Vitamin D
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 33762428

Group type: EXPERIMENTAL
Intervention: Epigallocatechin‐3‐gallate (EGCG) 800 mg daily for 18 months
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 34951974

Group type: EXPERIMENTAL
Intervention: DSJI (Disposable Syringe Jet Injector)
Number of subjects: 2720

Group type: COMPARATOR
Intervention: N&S (Needle and Syringe)
Number of subjects: 2720

Group type: EXPERIMENTAL
Intervention: IDA (Intradermal Adaptor)
Number of subjects: 2720

Group type: EXPERIMENTAL
Intervention: IDA
Number of subjects: 2720

Group type: EXPERIMENTAL
Intervention: DSJI
Number of subjects: 2720

Group type: EXPERIMENTAL
Intervention: IDA and DSJI
Number of subjects: 2720

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 2720
Study: 33810796

Group type: EXPERIMENTAL
Intervention: KB109 in addition to supportive self-care (SSC)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: KB109 in addition to SSC
Number of subjects: 400

Group type: COMPARATOR
Intervention: SSC alone
Number of subjects: 400
Study: 33069301

Group type: EXPERIMENTAL
Intervention: Cytisine (9 mg on day 0, gradually reduced to 1.5 mg by day 25)
Number of subjects: 2472

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2472

Group type: EXPERIMENTAL
Intervention: Cytisine
Number of subjects: 2472
Study: 36195897

Group type: EXPERIMENTAL
Intervention: Social norm feedback on antibiotic prescribing
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Social norm feedback plus online training on rational prescribing practice and communication strategies
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Social norm feedback plus online peer-moderated training on rational antibiotic prescribing, communication strategies, and sustainable behavior change
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2000
Study: 34830709

Group type: EXPERIMENTAL
Intervention: Internal conical connection implants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Internal hexagonal connection implants
Number of subjects: 30
Study: 35426033

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg capsule for 14 days during each chemotherapy cycle
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo for 14 days during each chemotherapy cycle
Number of subjects: 32
Study: 33651748

Group type: EXPERIMENTAL
Intervention: High-dose omega-3 fatty acids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose colchicine
Number of subjects: 0
Study: 32828167

Group type: EXPERIMENTAL
Intervention: Peer-delivered psychosocial intervention
Number of subjects: 1154

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 1154
Study: 34258637

Group type: EXPERIMENTAL
Intervention: 3D fat-saturated-CAIPIRINHA SPACE MRI
Number of subjects: 49

Group type: COMPARATOR
Intervention: 2D TSE MRI
Number of subjects: 49
Study: 33250314

Group type: EXPERIMENTAL
Intervention: 150 mg/day Oligopin®
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 35936217

Group type: EXPERIMENTAL
Intervention: Acetyl-L-Carnitine (ALC) 1000 mg three times per day for three consecutive days
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 35445808

Group type: EXPERIMENTAL
Intervention: Combined CPAP and tolterodine treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: CPAP treatment only
Number of subjects: 60
Study: 34213794

Group type: EXPERIMENTAL
Intervention: VR immersion (experimental group, n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Audio immersion (control group, n = 20)
Number of subjects: 40
Study: 34192396

Group type: EXPERIMENTAL
Intervention: Limosilactobacillus reuteri DSM‐17938
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 32775414

Group type: EXPERIMENTAL
Intervention: Random practice
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Constant practice
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 21
Study: 36240174

Group type: EXPERIMENTAL
Intervention: PINCER intervention
Number of subjects: 46
Study: 34051544

Group type: EXPERIMENTAL
Intervention: Immediate reduction from 15.5 to 0.4 mg of nicotine per gram of tobacco (mg/g)
Number of subjects: 1250

Group type: EXPERIMENTAL
Intervention: Gradual reduction to 0.4 mg/g
Number of subjects: 1250

Group type: COMPARATOR
Intervention: Control group with normal nicotine cigarettes (15.5 mg/g)
Number of subjects: 1250
Study: 33378308

Group type: EXPERIMENTAL
Intervention: Endovascular revascularization plus supervised exercise
Number of subjects: 212

Group type: COMPARATOR
Intervention: Supervised exercise only
Number of subjects: 212
Study: 34328109

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (500 mg capsule containing Lactobacillus acidophilus LA1, Bifidobacterium longum sp54 cs, and Bifidobacterium bifidum sp9 cs)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 507
Study: 36345556

Group type: EXPERIMENTAL
Intervention: Global Deficit Score (GDS) from neuropsychological measures
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: PTSD symptom severity assessed using the PTSD Checklist‐Military Version
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Performance in the verbal learning and memory domain
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Multiple linear regressions with GDS and PTSD symptom severity
Number of subjects: 119
Study: 32214139

Group type: EXPERIMENTAL
Intervention: Epidural bolus (0.15% ropivacaine 0.3 ml·kg‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Continuous epidural infusion (0.15% ropivacaine 0.3 ml·kg‐1)
Number of subjects: 40
Study: 34212185

Group type: EXPERIMENTAL
Intervention: Rehabilitation Gaming System (RGS)
Number of subjects: 20
Study: 33661714

Group type: EXPERIMENTAL
Intervention: Oat flour and pea protein (protein)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Oat flour, pea starch and pea protein (starch+protein)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Oat flour, pea fibre and pea protein (fibre+protein)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Oat flour, pea starch and pea protein (fibre+starch+protein)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Oat flour (control)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Oat flour and pea starch (starch)
Number of subjects: 26
Study: 32070793

Group type: EXPERIMENTAL
Intervention: Early Manual Therapy Group (EMTG)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard Physiotherapy Group (SPG)
Number of subjects: 39
Study: 35489646

Group type: EXPERIMENTAL
Intervention: HomeStyles‐2 nutrition education program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control program
Number of subjects: 0
Study: 33283421

Group type: EXPERIMENTAL
Intervention: HCH nursing care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (traditional nursing care)
Number of subjects: 60
Study: 36343423

Group type: EXPERIMENTAL
Intervention: Rosemary capsules, 1 capsule twice a day for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo, 1 capsule twice a day for 8 weeks
Number of subjects: 0
Study: 33066761

Group type: EXPERIMENTAL
Intervention: Pyridostigmine bromide 60 mg/day P.O.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34791423

Group type: EXPERIMENTAL
Intervention: SRC+CIH
Number of subjects: 210

Group type: COMPARATOR
Intervention: SRC
Number of subjects: 210
Study: 33945928

Group type: EXPERIMENTAL
Intervention: Sense of social connectedness and information source (newspapers, TV, word of mouth)
Number of subjects: 1300
Study: 35039300

Group type: EXPERIMENTAL
Intervention: LEGO-based therapy
Number of subjects: 248

Group type: COMPARATOR
Intervention: Usual support
Number of subjects: 248
Study: 32030940

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan (Entresto®)
Number of subjects: 0

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 0
Study: 34521118

Group type: EXPERIMENTAL
Intervention: EndoRotor ablation
Number of subjects: 30
Study: 34362303

Group type: EXPERIMENTAL
Intervention: 0.4 g/kg 10% IVIG administered every two weeks for five doses
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.9% saline administered every two weeks for five doses (control)
Number of subjects: 50
Study: 33004131

Group type: EXPERIMENTAL
Intervention: Canakinumab 50 mg
Number of subjects: 10061

Group type: EXPERIMENTAL
Intervention: Canakinumab 150 mg
Number of subjects: 10061

Group type: EXPERIMENTAL
Intervention: Canakinumab 300 mg
Number of subjects: 10061

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10061
Study: 35550645

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT-SAD)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Light therapy (LT)
Number of subjects: 160